PepTivator® Parvovirus B19 VP1u is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap, covering the complete VP1u domain (aa 1-227) of the VP1 protein, (UniProt ID: Q9PZT0).
In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.
Related products for PepTivator® Parvovirus B19 VP1u
PepTivator® Parvovirus B19 VP1u is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap, covering the complete VP1u domain (aa 1-227) of the VP1 protein, (UniProt ID: Q9PZT0).
In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.
Parvovirus B19 is a small, non-enveloped DNA virus belonging to the Parvoviridae family and the Erythroparvovirus genus. It is the etiologic agent of erythema infectiosum (fifth disease), a common childhood illness characterized by a “slapped cheek” rash and other flu-like illnesses. The parvovirus B19 capsid is composed of two major structural proteins: VP1 and VP2. VP1 differs from VP2 only in a unique N-terminal extension composed of 227 aa, known as the VP1 unique region (VP1u). This VP1u domain plays a critical role in the viral life cycle and immunogenicity. Moreover, VP1u is a prominent target of the host immune response and has been shown to induce strong T cell and antibody responses, making it a valuable component for immunological assays and vaccine research.
The PepTivator Peptide Pools have been specially developed for efficient in vitro Stimulation of antigen-specific CD4+ and CD8+ T cells, as peptides of 15 amino acid length with 11 amino acid overlap represent the optimized solution for stimulating both CD4+ and CD8+ T cells in various applications. Stimulation of T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and upregulation of activation markers, which then allows the detection or isolation of antigen-specific T cells. Quantitative, phenotypical, or functional analysis of antigen-specific T cell immunity can provide important information on the natural course of the natural course of immune responses.